These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20930169)

  • 1. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
    Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
    Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.
    Bu DX; Johansson ME; Ren J; Xu DW; Johnson FB; Edfeldt K; Yan ZQ
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2604-10. PubMed ID: 20864668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
    Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
    Furgeson SB; Simpson PA; Park I; Vanputten V; Horita H; Kontos CD; Nemenoff RA; Weiser-Evans MC
    Cardiovasc Res; 2010 May; 86(2):274-82. PubMed ID: 20051384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.
    Tas SW; Vervoordeldonk MJ; Hajji N; May MJ; Ghosh S; Tak PP
    Arthritis Res Ther; 2006; 8(4):R86. PubMed ID: 16684367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.
    Grassia G; Maddaluno M; Guglielmotti A; Mangano G; Biondi G; Maffia P; Ialenti A
    Cardiovasc Res; 2009 Dec; 84(3):485-93. PubMed ID: 19592568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of c-Jun NH2 terminal kinase and p38MAPK in rapamycin-mediated inhibition of neointimal formation in rat carotid arteries.
    Omura T; Yoshiyama M; Izumi Y; Kim S; Matsumoto R; Enomoto S; Kusuyama T; Nishiya D; Nakamura Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):519-25. PubMed ID: 16160607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylbritannilactone Inhibits Neointimal Hyperplasia after Balloon Injury of Rat Artery by Suppressing Nuclear Factor-{kappa}B Activation.
    Liu B; Han M; Wen JK
    J Pharmacol Exp Ther; 2008 Jan; 324(1):292-8. PubMed ID: 17911374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
    Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
    Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling.
    Kanellakis P; Pomilio G; Walker C; Husband A; Huang JL; Nestel P; Agrotis A; Bobik A
    Atherosclerosis; 2009 May; 204(1):66-72. PubMed ID: 18930230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
    Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
    Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
    Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A
    Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
    Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
    Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury.
    Deliri H; Meller N; Kadakkal A; Malhotra R; Brewster J; Doran AC; Pei H; Oldham SN; Skaflen MD; Garmey JC; McNamara CA
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):110-6. PubMed ID: 20947825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.